Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, ...
In the latest trading session, Cathie Wood's ARK ETFs continued to adjust their portfolios, with significant moves seen in both buying and selling across various sectors. The largest transaction for ...
Opportunity knocks thrice for the iconic growth investor.
In the biotech space, ARK acquired 127,184 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) through its ARKK and ARKG ETFs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results